NWU Institutional Repository

2-Heteroarylidene-1-indanone derivatives as inhibitors of monoamine oxidase

Loading...
Thumbnail Image

Date

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier

Abstract

In the present study a series of fifteen 2-heteroarylidene-1-indanone derivatives were synthesised and evaluated as inhibitors of recombinant human monoamine oxidase (MAO) A and B. These compounds are structurally related to series of heterocyclic chalcone derivatives which have previously been shown to act as MAO-B specific inhibitors. The results document that the 2-heteroarylidene-1-indanones are in vitro inhibitors of MAO-B, displaying IC50 values of 0.0044–1.53 μM. Although with lower potencies, the derivatives also inhibit the MAO-A isoform with IC50 values as low as 0.061 μM. An analysis of the structure-activity relationships for MAO-B inhibition indicates that substitution with the methoxy group on the A-ring leads to a significant enhancement in MAO-B inhibition compared to the unsubstituted homologues while the effect of the heteroaromatic substituent on activity, in decreasing order is: 5-bromo-2-furan > 5-methyl-2-furan > 2-pyridine ≈ 2-thiophene > cyclohexyl > 3-pyridine ≈ 2-furan. It may therefore be concluded that 2-heteroarylidene-1-indanone derivatives are promising leads for the design of MAO inhibitors for the treatment of Parkinson’s disease and possibly other neurodegenerative disorders

Description

Citation

Nel, M.S. et al. 2016. 2-Heteroarylidene-1-indanone derivatives as inhibitors of monoamine oxidase. Bioorganic chemistry, 69:20-28. [https://doi.org/10.1016/j.bioorg.2016.09.004]

Endorsement

Review

Supplemented By

Referenced By